Aspen Pharmacare | APN - Sales Revenues

Stock Price
13,843.00
Daily Change
-99.00 -0.71%
Monthly
7.14%
Yearly
16.02%
Q2 Forecast
13,633.48

Aspen Pharmacare reported ZAR17.08B in Sales Revenues for its fiscal semester ending in December of 2025.





Sales Change Date
Aspen Pharmacare ZAR 17.08B 4.32B Dec/2025
Cipla INR 65.41B 9.77B Mar/2026
Dr.Reddys Laboratories INR 75.46B 11.81B Mar/2026
Jiangsu Hengrui CNY 8.14B 300M Mar/2026
Kalbe Farma IDR 9.34T 431B Mar/2026
Life Healthcare ZAR 12.97B 838M Dec/2025
Netcare ZAR 13.67B 990M Dec/2025
Richter Gedeon HUF 214.69B 26.79B Sep/2025